Author

Jianqiu Du

The Wistar InstituteORCID 0009-0001-2626-6590Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:proteomics· 3 Research Focus:host-pathogen & immune response· 2 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Organism:human· 1 Organism:non-human primate· 1

Frequent Co-Authors

Jesper PalleseniD· 3 shared Amelia EscolanoiD· 2 shared Beatrice H. HahniD· 2 shared Daniel W. KulpiD· 2 shared David B. WeineriD· 2 shared George M. ShawiD· 2 shared Jiayan CuiiD· 2 shared Rumi HabibiD· 2 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

Jesper PallesenORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologybioRxivPreprintJul 2, 2026

Generation and MHC class II loading of an endogenous influenza epitope revealed by a T cell receptor-like antibody

Linlin Yang, Michael John Hogan, Stephen D. Carro…·Laurence Crane Eisenlohr

An mRNA vaccine-based pipeline generated a TCR-like antibody to study noncanonical MHC-II antigen processing of an influenza epitope.

DOI 10.64898/2026.06.25.734564

proteomicsexperimental assay

𝕏 PostBluesky

ImmunologyProceedings of the National Academy of SciencesPeer-reviewedApr 29, 2026

Deep Mining of the Human Antibody Repertoire Identifies Frequent and Genetically Diverse CDRH3 Topologies Targetable by Vaccination

Rumi Habib, Shahlo O. Solieva, Zi Jie Lin…·Daniel W. Kulp

The paper identifies frequent and genetically diverse CDRH3 topologies in the human antibody repertoire that can be targeted by vaccination to elicit broadly neutralizing antibodies.

8 citationstop 3%

humanproteomics

𝕏 PostBluesky

ImmunologybioRxivPreprintSep 4, 2025

Rapid elicitation of a new class of neutralizing N332-glycan independent V3-glycan antibodies against HIV-1 in nonhuman primates.

Ignacio Relaño-Rodríguez, Jianqiu Du, Zi Jie Lin…·Amelia Escolano

This paper introduces WIN332, an engineered immunogen that elicits N332-glycan-independent V3-glycan antibodies in nonhuman primates after a single immunization.

DOI 10.1101/2025.09.04.674340

non-human primateproteomics

𝕏 PostBluesky